Pace links up with V-Tech to offer cardiac test panel
This article was originally published in Clinica
Executive Summary
Pace, a Canadian developer of diagnostic tests, has signed an exclusive OEM deal with V-Tech of El Monte, California, for the manufacture of rapid, quantitative tests to detect cardiac markers, including Pace's glycogen phosphorylase BB marker (GPBB). Under the agreement, Pace will pay $400,000 to develop GPBB tests jointly with V-Tech. In return, Pace will receive exclusive rights to the use of V-Tech's technology in testing for GPBB and non-exclusive rights to market and sell CK-MB and myoglobin tests, using similar technology.